Search Results - "Scardino, E"
-
1
Local staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection
Published in Radiologia medica (01-06-2008)“…Purpose This study was undertaken to compare the local staging of penile cancer by magnetic resonance imaging (MRI) combined with pharmacologically induced…”
Get full text
Journal Article -
2
Magnetic resonance imaging combined with artificial erection for local staging of penile cancer
Published in Urology (Ridgewood, N.J.) (01-06-2004)“…To assess magnetic resonance imaging (MRI) combined with artificial erection for local staging of penile cancer. We compared local clinical, MRI plus…”
Get full text
Journal Article -
3
Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer
Published in Annals of oncology (01-03-2009)“…Background: There is a need for active agents with a better safety profile than docetaxel, yet good activity, for patients with hormone-refractory prostate…”
Get full text
Journal Article -
4
Vinorelbine-based Chemotherapy in Hormone-refractory Prostate Cancer
Published in Anticancer research (01-05-2006)“…Background: No consensus exists regarding further therapy for the management of hormone-refractory prostate cancer. In this phase II study, the combination of…”
Get full text
Journal Article -
5
Gn-RH Antagonist Possible Response, After Gn-RH Agonist Failure in a Man with Metastatic Prostate Cancer
Published in Anticancer research (01-01-2005)“…Gn-RH agonists or surgical castration are considered standard treatment for patients affected by metastatic prostate cancer. Despite greater cost, chemical…”
Get full text
Journal Article -
6
Late solitary thyroid carcinoma metastasis to the kidney: a case report
Published in Anticancer research (01-01-2003)“…Secondary tumour to the kidney is quite frequent. Even if, theoretically, all solid tumours may give rise to renal metastasis, secondary lesions to the kidney…”
Get more information
Journal Article -
7
Spermatic cord liposarcoma: a report of four cases
Published in Anticancer research (01-05-2003)“…Spermatic cord liposarcoma is a rare pathology (1-4); currently about one hundred cases are documented. The therapy of choice is surgery, followed sometimes by…”
Get more information
Journal Article -
8
Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone
Published in European urology (01-01-1997)“…Experimental and preliminary clinical studies have suggested that the pineal hormone melatonin (MLT) may stimulate hormone receptor expression on both normal…”
Get more information
Journal Article -
9
Prognostic factors of the clinical response to subcutaneous immunotherapy with interleukin-2 alone in patients with metastatic renal cell carcinoma
Published in Oncology (01-01-1994)“…The intravenous immunotherapy with interleukin 2 (IL-2) represents one of the most active therapies of metastatic renal cell carcinoma (RCC). Recently, it has…”
Get more information
Journal Article -
10
Antidote-mediated control of an anticoagulant aptamer in vivo
Published in Nature biotechnology (01-11-2004)“…Patient safety and treatment outcome could be improved if physicians could rapidly control the activity of therapeutic agents in their patients. Antidote…”
Get full text
Journal Article -
11
Generation of Species Cross-reactive Aptamers Using “Toggle” SELEX
Published in Molecular therapy (01-12-2001)“…Species cross-reactivity facilitates the preclinical evaluation of potentially therapeutic molecules in animal models. Here we describe an in vitro selection…”
Get full text
Journal Article -
12
RNA aptamers as reversible antagonists of coagulation factor IXa
Published in Nature (London) (05-09-2002)“…Many therapeutic agents are associated with adverse effects in patients. Anticoagulants can engender acute complications such as significant bleeding that…”
Get full text
Journal Article -
13
A randomized study of low-dose interleukin-2 subcutaneous immunotherapy versus interleukin-2 plus interferon-alpha as first line therapy for metastatic renal cell carcinoma
Published in Tumori (31-12-1993)“…IL-2 given subcutaneously in combination with interferon-alpha 2b (IFN) appears to induce a response rate comparable to that obtained with IL-2 intravenous…”
Get more information
Journal Article -
14
Correlation between pretreatment serum levels of neopterin and response to interleukin-2 immunotherapy in cancer patients
Published in Journal of biological regulators and homeostatic agents (01-01-1995)“…IL-6 levels have been proven to correlate with resistance to IL-2 immunotherapy. Since IL-6 may be produced by both macrophages and TH2 lymphocytes, it is not…”
Get more information
Journal Article -
15
-
16
-
17
Lymphocytosis decline is not responsible for tumor progression in cancer patients chronically treated with interleukin-2
Published in Tumori (31-08-1994)“…The antitumor activity of IL-2 is mediated by an increase in lymphocyte number. Moreover, our previous studies have shown that therapy for 1 week/month with…”
Get more information
Journal Article -
18
Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy: Preliminary Report
Published in European urology (01-05-2006)“…The various prostate biopsy methods are usually compared in terms of the diagnosis rate of prostate cancer. However, the prevalence of cancer in patients with…”
Get full text
Journal Article -
19
Synchronous Collecting Duct Carcinoma and Papillary Renal Cell Carcinoma: A Case Report and Review of the Literature
Published in Anticancer research (01-01-2005)“…The coexistence of multiple and synchronous primary neoplasms in the same organ (including kidney) has only rarely been described in the literature. We herein…”
Get full text
Journal Article -
20
Localization of Avidin in Superficial Bladder Cancer: A Potentially New Approach for Radionuclide Therapy
Published in European urology (01-11-2003)“…Objective: To verify whether native avidin, made radioactive through the binding with technetium-99m labeled biotin ( 99 m Tc -biotin), selectively accumulated…”
Get full text
Journal Article